Hypothalamic-Pituitary-Testicular Axis Disruptions in Older Men Are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Context: The cause of declining testosterone (T) in aging men and their relationships with risk factors are unclear. Objective: The objective of the study was to investigate the relationships between lifestyle and health with reproductive hormones in aging men. Design: This was a baseline cross-sectional survey on 3200 community-dwelling men aged 40–79 yr from a prospective cohort study in eight European countries. Results: Four predictors were associated with distinct modes of altered function: 1) age: lower free T (FT; −3.12 pmol/liter·yr, P < 0.001) with raised LH, suggesting impaired testicular function; 2) obesity: lower total T (TT; −2.32 nmol/liter) and FT (−17.60 pmol/liter) for body mass index (BMI; ≥ 25 to < 30 kg/m2) and lower TT (−5.09 nmol/liter) and FT (−53.72 pmol/liter) for BMI 30 kg/m2 or greater (P < 0.001–0.01, referent: BMI < 25 kg/m2) with unchanged/decreased LH, indicating hypothalamus/pituitary dysfunction; 3) comorbidity: lower TT (−0.80 nmol/liter, P < 0.01) with unchanged LH in younger men but higher LH in older men; and 4) smoking: higher SHBG (5.96 nmol/liter, P < 0.001) and LH (0.77 U/liter, P < 0.01) with increased TT (1.31 nmol/liter, P < 0.001) but not FT, compatible with a resetting of T-LH-negative feedback due to elevated SHBG. Conclusions: Complex multiple alterations in the hypothalamic-pituitary-testicular axis function exist in aging men against a background of progressive age-related testicular impairment. These changes are differentially linked to specific risk factors. Some risk factors operate independently of but others interact with age, in contributing to the T decline. These potentially modifiable risk factors suggest possible preventative measures to maintain T during aging in men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that obesity in men is associated with low testosterone and reduced sex hormone-binding globulin (SHBG) levels (19,20,21,22,23).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [23]
In the citing paper
“An obesityassociated decline in SHBG might partially explain the observed fall in testosterone levels (19,20,21,22,23).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [23]
In the citing paper
“Indeed, epidemiological data suggest that the single most powerful predictor of low testosterone is obesity, and that obesity is a major contributor of the age-associated decline in testosterone levels.16”
From Lowered testosterone in male obesity: Mechanisms, morbidity and management (2014) · cites this paper as [16]
In the citing paper
“Both total testosterone (5.9 nmol l−1) and free testosterone (54 pmol l−1) levels were lower in obese compared to lean men, with lesser but still significant reduction in overweight men (total T 2.3 nmol l−1, free T 18 pmol l−1)16.”
From Lowered testosterone in male obesity: Mechanisms, morbidity and management (2014) · cites this paper as [16]
In the citing paper
“Notably, one study reported cases of males with acquired hypogonadotropic hypogonadism remaining fertile after T treatment (99).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [99]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Free T levels were derived from total T, SHBG, and albumin concentrations ( 10 ).”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225 · cited 1×
“Although SHBG was negatively associated with increasing strata of obesity, the positive relationship with age was well preserved in obese as well as in the nonobese men, clearly demonstrating the concurrent but opposite (and separate) effects of obesityandageonSHBG(27).Obesityisassociatedwithinsulin resistance ( 28 ),…”
BackgroundBroken Limits to Life Expectancy
Oeppen, J., & Vaupel, J. W. (2002) · Science · doi:10.1126/science.1069675 · Cited by 2,819
Glinoer, D. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0300 · Cited by 1,364 · cited 1×
“Our findings suggest that the apparent increase in total T in smokers occurs through a primary increase in SHBG with a compensatory rise in LH. After this resetting of the “gonadostat,” smokers’ free T remained unchanged.Thissituationisthesameasthe responseofthepituitary-thyroidaxistoincreased thyroid-binding globulin…”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
The Free Hormone Hypothesis: A Physiologically Based Mathematical Model*
MENDEL, C. M. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-232 · Cited by 961
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865 · cited 1×
“Obesity is associated with peripheral and central insulin resistance (30) and proinflammatory cytokine production (TNF and IL-6) from adipocytes (31) and central nervous system endocannibinoid release ( 32 ), all of which are potential candidates for abrogating hypothalamic endocrine and downstream reproductive axis f…”
Backgroundvan den Beld, A. W. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3276 · Cited by 622 · cited 1×
“The present study confirms the age-related cross-sectional trendsincirculatingTincommunity-dwellingmen(6).Themagnitude of fall in total T is modest (0.4% per annum); this is similartosome(16, 17 )butlessthanthatofothercross-sectional studies typically reporting a 0.4–2% annual decline (18–20).”
ResultInfluential
Cited by
Items 401–500 of 938
Endogenous testosterone as a predictor of prostate growing disorders in the aging male
Porcaro, A. B., Amigoni, N., Tafuri, A., Rizzetto, R., Shakir, A., Tiso, L., Cerrato, C., Lacola, V., Antoniolli, S. Z., Gozzo, A., et al. (2021) · International Urology and Nephrology · doi:10.1007/s11255-020-02747-w · Cited by 18
“In the European Male Aging study, it has been shown that endogenous testosterone levels were decreased for age groups and BMI categories because of impairment of testicular function as well as hypothalamus/ pituitary axis [26].”
BackgroundEffects of androgens on glucose metabolism
Umapathysivam, M. M., Grossmann, M., & Wittert, G. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101654 · Cited by 19
Genome-wide association studies on serum sex steroid levels
Vandenput, L., & Ohlsson, C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.009 · Cited by 21
“Body mass index (BMI) is an important determinant of serum testosterone levels (Haring et al., 2012b; Harman et al., 2001; Muller et al., 2003; Orwoll et al., 2006; Svartberg et al., 2003; Travison et al., 2007; Wu et al., 2008).”
BackgroundInfluentialHerrera‐Covarrubias, D., Coria‐Ávila, G. A., Xicoténcatl, P. C., Fernández–Pomares, C., Manzo, J. G., Aranda-Abreu, G. E., & Hernández‐Aguilar, M. E. (2015) · Experimental Oncology · doi:10.31768/2312-8852.2015.37(1):13-18 · Cited by 18
“testosterone (T) decrease by more than 50% as compared to the levels observed at age 20 [10–13], and other hormones such as prolactin (PRL) increase by at least 30% above normal levels in elderly [14].”
ResultMatsumoto, A. M., & Bremner, W. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00019-8 · Cited by 27
Matsumoto, A. M., & Bremner, W. J. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00019-5 · Cited by 18
Best practices for including sex as a variable in appetite research
Geary, N., Asarian, L., & Leeners, B. (2025) · Appetite · doi:10.1016/j.appet.2024.107840 · Cited by 18
Metabolism of testosterone during weight loss in men with obesity
Van de Velde, F., Deventer, K., Van Gansbeke, W., Van Eenoo, P., Van Renterghem, P., Fiers, T., Reyns, T., Kaufman, J. M., Van Nieuwenhove, Y., & Lapauw, B. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105851 · Cited by 17
Theodoraki, A., & Bouloux, P.-M. G. (2009) · Menopause international · doi:10.1258/mi.2009.009025 · Cited by 17
DeLay, K. J., & Köhler, T. (2016) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.04.011 · Cited by 17
Busnelli, A., Somigliana, E., & Vercellini, P. (2017) · Human Reproduction · doi:10.1093/humrep/dex032 · Cited by 19
“In this regard, the EMAS reported that 75% of men with symptomatic hypogonadism were overweight or obese (Wu et al., 2008, 2010; Pfaff and Joels, 2016).”
BackgroundMontagna, G., Balestra, S., D’Aurizio, F., Romanelli, F., Benagli, C., Tozzoli, R., Risch, L., Giovanella, L., & Imperiali, M. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1201 · Cited by 17
Impact of age, body weight and metabolic risk factors on steroid reference intervals in men
Mezzullo, M., Dalmazi, G. D., Fazzini, A., Baccini, M., Repaci, A., Gambineri, A., Vicennati, V., Pelusi, C., Pagotto, U., & Fanelli, F. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0928 · Cited by 20
Corona, G., Rastrelli, G., Dicuio, M., Concetti, S., Minnetti, M., Pivonello, R., Isidori, A. M., Sforza, A., & Maggi, M. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03208-3 · Cited by 19
Abbara, A., Narayanaswamy, S., Izzi‐Engbeaya, C. N., Comninos, A. N., Clarke, S. A., Malik, Z. A., Papadopoulou, D., Clobentz, A., Sarang, Z., Bassett, P., et al. (2018) · Neuroendocrinology · doi:10.1159/000488452 · Cited by 18
Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult Men
Rabiee, A., Dwyer, A. A., Caronia, L. M., Hayes, F. J., Yialamas, M. A., Andersen, D. K., Thomas, B. J., Torriani, M., & Elahi, D. (2010) · Endocrine Research · doi:10.3109/07435801003705601 · Cited by 19
Low testosterone in ageing men: a modifiable risk factor for frailty?
O’Connell, M. D. L., Ravindrarajah, R., Tajar, A., & Wu, F. C. W. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.08.003 · Cited by 16
Self-citationCombination of the biomarkers for aging and cancer? - Challenges and current status
Li, D., Ju, F., Wang, H., Fan, C., Jacob, J. C., Gul, S., Zaliani, A., Wartmann, T., Polidori, M. C., Bruns, C. J., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101783 · Cited by 18
Total testosterone may not decline with ageing in K orean men aged 40 years or older
Kim, Y., Hong, D., Lee, D., Joo, N., & Kim, K. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04375.x · Cited by 16
DeFina, L. F., Radford, N. B., Leonard, D. S., Wilson, R. K., Cooper, T. C., Clark, S. M., Willis, B. L., Vega, G. L., Barlow, C. E., Farrell, S. W., et al. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.09.004 · Cited by 18
Lim, C. A.-R., Nightingale, T. E., Elliott, S., & Krassioukov, A. V. (2019) · Spinal Cord · doi:10.1038/s41393-019-0404-z · Cited by 20
“In able-bodied individuals the association between metabolic disorders and hypogonadism is multidirectional; low testosterone levels can contribute to adipose tissue accumulation and insulin resistance [39, 40] and visceral adiposity can lead to low testosterone levels [41, 42].”
BackgroundZang, Z. J., Ji, S. Y., Wang, D., Zhang, Y. N., Zhang, E. H., & Zhang, B. (2014) · The Aging Male · doi:10.3109/13685538.2014.963042 · Cited by 17
“steadily at 30–40 years of age at a rate of about 1% every year [8,9], and result in 20% of men over 60 years and 50% of men”
BackgroundSamaras, N., Samaras, D., Lang, P. O., Forster, A., Pichard, C., Frangos, E., & Meyer, P. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.11.009 · Cited by 23
“4–1% [5,8–10] resulting to levels beneath the refrence range in 20% of healthy men over 60 and 30–50% over 0 [6,11].”
Testosterone and cardiovascular risk in patients with erectile dysfunction.
Corona, G., Rastrelli, G., Balercia, G., Sforza, A., Forti, G., & Maggi, M. (2012) · PubMed · doi:10.3275/8063 · Cited by 16
Self-citationFonctions testiculaires du sujet âgé
Sibert, L., Lacarrière, E., Safsaf, A., & Rives, N. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2013.12.003 · Cited by 18
Serum chemerin levels are negatively associated with male fertility and reproductive hormones
Bobjer, J., Katrinaki, M., Dermitzaki, E., Margioris, A. N., Giwercman, A., & Tsatsanis, C. (2018) · Human Reproduction · doi:10.1093/humrep/dey310 · Cited by 16
“First, we compared chemerin levels between subfertile men and controls using regression analysis, with and without adjustment for established confounders (age, BMI and smoking) (Wu et al., 2008).”
MethodSelf-citationThe relationship between gender and pharmacology
Younes, S. (2024) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2024.100192 · Cited by 20
“Furthermore, certain medications, including glucocorticoids and opioids, can suppress the gonadal axis (Wu et al., 2008; Bawor et al., 2015; de Vries et al., 2020).”
BackgroundSchneider, G., Zitzmann, M., Gromoll, J., Ladwig, K., & Berger, K. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.016 · Cited by 15
“This has been shown in vitro and also in different populations in testosterone-sensitive tissues (Zitzmann et al., 2003a,b; Zitzmann and Nieschlag, 2007; review: Zitzmann, 2007).”
BackgroundTestosterone therapy improves well being and psychological health
Akerman, J., Kovac, J. R., & Lipshultz, L. I. (2017) · Current Opinion in Urology · doi:10.1097/mou.0000000000000440 · Cited by 17
“No modality of TTh has been shown to be more efficacious than another in resolving male hypogonadal symptoms. hypogonadal men were symptomatic compared with only 2% of those included in the European Male Aging Study [15,16].”
BackgroundMale Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male
Ahmed, K., Hatzimouratidis, K., & Muneer, A. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.12.004 · Cited by 16
An, N., Zhu, J., Ren, L., Liu, X., Zhou, T., Huang, H., Sun, L., Ding, Z. Y., Li, Z., Cheng, X., et al. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.01.062 · Cited by 16
Sex Disparity in Severity of Lung Lesions in Newly Identified Tuberculosis Is Age-Associated
Chu, Y., Soodeen-Lalloo, A. K., Huang, J., Yang, G., Chen, F., Yin, H., Sha, W., Huang, X., Shi, J., & Feng, Y. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00163 · Cited by 18
Skiba, R., Matyjek, A., Syryło, T., Niemczyk, S., & Rymarz, A. (2020) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s275554 · Cited by 16
Testosterone treatment of late-onset hypogonadism – benefits and risks
Snyder, P. J. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09712-1 · Cited by 16
Diagnosis of hypogonadism in ageing men
Kaufman, J. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09763-4 · Cited by 20
Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
Atan, A., Tuncel, A., Yeşil, S., & Balbay, D. (2013) · Advances in Urology · doi:10.1155/2013/275945 · Cited by 16
Gawałek, M., & Sliwowska, J. H. (2015) · Reproductive Biology · doi:10.1016/j.repbio.2015.04.001 · Cited by 17
Halmenschlager, G., Rhoden, E. L., & Riedner, C. E. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0724-x · Cited by 16
“Although there is a considerable body of evidence in the literature documenting the age-related decline in androgen levels [4–14], few studies have adjusted their results to BMI and glucose levels concurrently [8, 11, 14].”
BackgroundInfluentialKratzik, C., Womastek, I., Bieglmayer, C., Schatzl, G., Lackner, J. E., Freibauer, C., & Lunglmayr, G. (2011) · PubMed · Cited by 17
Dedov, I. I., Mel'nichenko, G. A., Rozhivanov, R. V., & Курбатов, Д. Г. (2015) · Problems of Endocrinology · doi:10.14341/probl201561560-71 · Cited by 17
“С возрастом у мужчин отмечается снижение уровня тестостерона (зафиксировано ежегодное снижение уровня циркулирующего тестостерона на 0,4—2,0% начиная с 30-летнего возраста) [3, 4].”
Jastrzębska, S., Walczak-Jędrzejowska, R., Kramek, E., Marchlewska, K., Oszukowska, E., Filipiak, E., Kula, K., & Słowikowska‐Hilczer, J. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0028 · Cited by 17
“[9] observe that the effect of increasing BMI and waist size on circulating testosterone was more substantial than that of age.”
BackgroundResultInfluentialSelf-citationMatsumoto, A. M. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.04.004 · Cited by 17
“Endocrine reviews (2018) 39(3):369–386.”
BackgroundInfluentialHosseini‐Marnani, E., Mollahosseini, M., Gheflati, A., Ghadiri‐Anari, A., & Nadjarzadeh, A. (2019) · Andrologia · doi:10.1111/and.13343 · Cited by 18
“In addition to these statements, the fact that vitamin D is strongly associated with androgen levels in men has been supported in previous studies (Chen et al., 2008; Wehr et al., 2010; Wu et al., 2008).”
ResultAndrogen Excess and Deficiency: Analytical and Diagnostic Approaches
Heijboer, A. C., & Hannema, S. E. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad146 · Cited by 14
Low Testosterone in Male Cancer Patients and Survivors
Xu, P. J., Choi, E. J., White, K. M., & Yafi, F. A. (2020) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.03.004 · Cited by 16
Aging and sex hormones in males
Decaroli, M. C., Vincentis, S. D., & Rochira, V. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.014 · Cited by 18
Novel androgen therapies including selective androgen receptor modulators
Kang, J., Chen, R., Tharakan, T., & Minhas, S. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101686 · Cited by 16
Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity
Paduch, D. A., Dabaja, A. A., Wosnitzer, M. S., Mielnik, A., Bolyakov, A., & Schlegel, P. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.123681 · Cited by 14
Testosterone Deficiency in Men
(2008) · Oxford University Press eBooks · doi:10.1093/med/9780199545131.001.0001 · Cited by 14
Li, Y., Li, S., Xu, S., Yu, H., Tang, L., Liu, X., Wang, X., Zhang, Y., Zhang, K., Mi, S., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200233 · Cited by 14
Hypotestosteronaemia in the aging male: should we treat it?
Christe, N., & Meier, C. A. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14216 · Cited by 14
Erectile Dysfunction as an Obesity-Related Condition in Elderly Men with Coronary Artery Disease
Biernikiewicz, M., Sobieszczańska, M. I., Szuster, E., Pawlikowska‐Gorzelańczyk, A., Janocha, A., Roźek-Piechura, K., Rusiecka, A., Gebala, J., Okrzymowska, P., & Kałka, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072087 · Cited by 15
“Furthermore, a decrease in free testosterone level was significantly higher in men with obesity (by 5.09 nmol/L; p < 0.001), in comparison to normal-weight men [14].”
InfluentialLi, Y., Zhang, C., Cheng, H., Lv, L., Zhu, X., Ma, M., Xu, Z., He, J., Xie, Y., Yang, X., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112522 · Cited by 14
“One of the most relevant age-related changes in men is the decline in testosterone levels, particularly plasma levels (Wu et al., 2008; Matsumoto, 2002).”
BackgroundOff label therapies for testosterone replacement
DiGiorgio, L., & Sadeghi‐Nejad, H. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.08.15 · Cited by 16
“According to the European Male Aging Study (EMAS), 85% of hypogonadal men are classified as secondary (1).”
BackgroundHow does body mass index affect semen parameters and reproductive hormones in infertile males?
Baydilli, N., Selvi, İ., Akınsal, E. C., Zararsız, G. E., & Ekmekçioğlu, O. (2020) · Urology Research and Practice · doi:10.5152/tud.2020.19243 · Cited by 16
The Relationship Between PSA and Total Testosterone Levels in Men with Prostate Cancer
Flores, J. M., Bernie, H. L., Miranda, E., Nascimento, B., Schofield, E., Benfante, N. E., Carlsson, S., & Mulhall, J. P. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.01.003 · Cited by 15
Testosterone deficiency and the aging male
Gryzinski, G. M., & Bernie, H. L. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-022-00555-7 · Cited by 13
Seland, M., Bjøro, T., Furre, T., Schreiner, T., Bollerslev, J., Fosså, S. D., Loge, J. H., Holte, H., & Kiserud, C. E. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0439-x · Cited by 13
“However, the numbers were small and secondary hypogonadism in males could also be explained by other factors, such as chronic systemic illnesses and obesity [32].”
BackgroundLate-Onset Hypogonadism and Testosterone Replacement in Older Men
Bhattacharya, R. K., & Bhattacharya, S. B. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.07.001 · Cited by 13
Gielen, E., O’Neill, T. W., Pye, S. R., Adams, J. E., Ward, K. A., Wu, F. C. W., Laurent, M. R., Claessens, F., Boonen, S., Vanderschueren, D., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2884-1 · Cited by 13
Self-citationEhala-Aleksejev, K., & Punab, M. (2017) · Andrologia · doi:10.1111/and.12952 · Cited by 13
“There is, however, an almost unanimous agreement that increased weight has a negative correlation with testosterone levels (Aggerholm et al., 2008; Chavarro, Toth, Wright, Meeker, & Hauser, 2010; Fejes, Koloszár, Szöllosi, Závaczki, & Pál, 2005; Jensen et al., 2004; Lu et al., 2015; Macdonald et al., 2013; Rohrmann et…”
BackgroundSelf-citationA review of the evolving landscape between the consumer Internet and men’s health
Balasubramanian, A., Yu, J., Srivatsav, A., Spitz, A., Eisenberg, M. L., Thirumavalavan, N., McBride, J. A., Lipshultz, L. I., & Pastuszak, A. W. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.09.29 · Cited by 13
Zhou, S.-J., Zhao, M., Yang, Y., Guan, D., Li, Z.-G., Ji, Y.-D., Zhang, B., Shang, X., Xiong, C., & Gu, Y. (2020) · Medicine · doi:10.1097/md.0000000000018605 · Cited by 15
“In addition, we found that the serum FT cut-off value was close to optimal for screening, evaluating and diagnosing AD, and was suitable for different age groups due to the ladder-like change patterns of serum FT. AD prevalence increased gradually with male aging, which showed a real and potential prevalence trendwhen…”
BackgroundInfluentialAssociation of sex hormones with hepatic steatosis in men with chronic hepatitis B
Chen, Q., Zhao, L., Mei, L., Zhong, R., Han, P., Yang, H., Li, Q., & Li, J. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.05.022 · Cited by 15
Tuin, J., Sanders, J., Buhl, B. M., van Beek, A. P., & Stegeman, C. A. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4297 · Cited by 14
“8% per ye ar in crosssectional studies[21, 22].”
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-388-7:191 · Cited by 13
Self-citationSato, K., Koyanagi‐Aoi, M., Uehara, K., Yamashita, Y., Shinohara, M., Lee, S., Reinhardt, A., Woltjen, K., Chiba, K., Miyake, H., et al. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.102392 · Cited by 13
Experiences and treatment patterns of hypogonadal men in a U.S. health system
Shortridge, E. F., Polzer, P. K., Donga, P. Z., Blanchette, C. M., Fang, Y. H., Burudpakdee, C., & Carswell, B. M. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12418 · Cited by 12
Figueiredo, M. G., Gagliano‐Jucá, T., & Basaria, S. S. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.12.002 · Cited by 13
Watling, C. Z., Kelly, R. K., Watts, E. L., Graubard, B. I., Petrick, J. L., Matthews, C. E., & McGlynn, K. A. (2024) · International Journal of Cancer · doi:10.1002/ijc.35244 · Cited by 14
Proteomic Insights into Senescence of Testicular Peritubular Cells from a Nonhuman Primate Model
Stöckl, J. B., Schmid, N., Flenkenthaler, F., Drummer, C., Behr, R., Mayerhofer, A., Arnold, G. J., & Fröhlich, T. (2020) · Cells · doi:10.3390/cells9112498 · Cited by 13
Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms
Lee, M. H., Shin, Y. S., & Kam, S. C. (2021) · International Neurourology Journal · doi:10.5213/inj.2040234.117 · Cited by 15
“However, the third phase corresponds to a decline in testosterone levels [42].”
BackgroundAging versus youth: Endocrine aspects of vulnerability for COVID-19
Oğuz, S. H., Koca, M., & Yıldız, B. O. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09656-y · Cited by 12
Nordio, M., Kumanov, P., Chiefari, A., & Puliani, G. (2021) · Basic and Clinical Andrology · doi:10.1186/s12610-021-00146-4 · Cited by 14
The Illusory Case for Treatment of an Invented Disease
Handelsman, D. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.682620 · Cited by 12
“The interpretation that the age-related decline in blood testosterone is related to comorbidities rather than ageing per se is supported by other longitudinal studies of reproductive hormones in male ageing (54, 55).”
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00020-4 · Cited by 19
Eendebak, R. J. A. H., Święcicka, A., Gromski, P. S., Pye, S. R., O’Neill, T. W., Marshall, A. D., Keevil, B. G., Tampubolon, G., Goodacre, R., Wu, F. C. W., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13305 · Cited by 12
Self-citationPark, Y., Lee, S. H., Lim, C. K., Choi, H. W., An, J. H., Park, C. W., Lee, H. S., Lee, J. S., & Seo, J. T. (2017) · Andrologia · doi:10.1111/and.12864 · Cited by 14
“Specifically, serum steroid levels decrease with advancing age, reflecting altered hypothalamic–pituitary–testicular axis regulation and decreased testicular function (Neaves, Johnson, Porter, Parker, & Petty, 1984; Wu et al., 2008).”
BackgroundTafuri, A., Sebben, M. A., Shakir, A., Pirozzi, M., Processali, T., Rizzetto, R., Amigoni, N., Brunelli, M., Migliorini, F., Siracusano, S., et al. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02398-x · Cited by 12
Testosterone deficiency syndrome: Diagnosis and treatment
García-Cruz, E., & Alcaraz, A. (2020) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2019.10.008 · Cited by 15
Functional and Nutritional State in Elderly Men With Compensated Hypogonadism
Uçak, S., Basat, O., & Karatemiz, G. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.03.006 · Cited by 13
Decreasing Testosterone with Increasing Age: More Factors, More Questions
Snyder, P. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0922 · Cited by 13
Testosterone and men's health: An in‐depth exploration of their relationship
Yassin, A. A., Al‐Zoubi, R. M., Alzubaidi, R. T., Kamkoum, H., Zarour, A. A., Garada, K., Elaarag, M., Al-Qudimat, A. R., Fares, Z. E., & Al-Ansari, A. A. (2025) · UroPrecision · doi:10.1002/uro2.115 · Cited by 19
Gender differences in cognitive outcome after cardiac arrest: A retrospective cohort study
Fillbrandt, A., & Frank, B. (2019) · Brain Injury · doi:10.1080/02699052.2019.1680866 · Cited by 13
Kurniawan, A. L., Hsu, C., Chao, J. C.-J., Paramastri, R., Lee, H.-A., Lai, P.-C., Hsieh, N., & Wu, S. V. (2021) · Nutrients · doi:10.3390/nu13010259 · Cited by 13
Fracture Incidence in Graves' Disease: A Population-Based Study
Khamisi, S., Udumyan, R., Sjölin, G., Calissendorff, J., Nyström, H. F., Holmberg, M., Hallengren, B., Lantz, M., Planck, T., Wallin, G., et al. (2023) · Thyroid · doi:10.1089/thy.2023.0162 · Cited by 12
Body composition and testosterone in men: a Mendelian randomization study
Ikehata, Y., Hachiya, T., Kobayashi, T., Ide, H., & Horie, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1277393 · Cited by 13
“Factors induced by obesity, such as the effects of systemic in fl ammation (11), increased aromatase activity (12), and leptin production (13), have all been suggested to interfere with testosterone production.”
BackgroundPresent and future association between obesity and hypogonadism in Italian male
Boddi, V., Barbaro, V., McNieven, P., Maggi, M., & Rotella, C. M. (2014) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2014.1.26 · Cited by 11
Allan, C. A., Peverill, R. E., Strauss, B. J., Forbes, E. A., & McLachlan, R. I. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.13 · Cited by 12
Wu, W., Ziglioli, F., & Maestroni, U. V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77761 · Cited by 11
Kim, D. K., Noh, J., Chang, Y., Lee, H. Y., Park, J. J., Ryu, S., & Kim, J. H. (2020) · Andrology · doi:10.1111/andr.12806 · Cited by 13
Zhong, S.-R., Yang, H.-H., Liao, C.-H., Yang, D., Tu, S.-K., Hung, C.-L., & Liao, C. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s282832 · Cited by 14
Stability of testosterone measured in male archival serum samples by two different methods
Gislefoss, R. E., Grimsrud, T. K., Høie, K., & Mørkrid, L. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.705888 · Cited by 12
Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome
Costa, I. C., Carvalho, H. N., Pacheco‐Figueiredo, L., Tomada, I., & Tomada, N. (2013) · International Journal of Endocrinology · doi:10.1155/2013/107869 · Cited by 11
Ullah, H., Nabi, G., Zubair, H., Ullah, R., & Shahab, M. (2018) · Andrologia · doi:10.1111/and.13219 · Cited by 11
“A decline in testosterone level and elevation of gonadotropic levels has been reported, previously (Wu et al., 2008).”
BackgroundHoermann, R., Fui, M. N. T., Krakauer, J. C., Krakauer, N. Y., & Grossmann, M. (2019) · International Journal of Obesity · doi:10.1038/s41366-018-0311-y · Cited by 15
Late-Onset Hypogonadism as Primary Testicular Failure
Swee, D. S., & Gan, E. H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00372 · Cited by 13
Porcaro, A. B., Tafuri, A., Sebben, M. A., Processali, T., Pirozzi, M., Shakir, A., Amigoni, N., Rizzetto, R., Brunelli, M., Migliorini, F., et al. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02263-6 · Cited by 11
Narinx, N., Nyamaah, J. A., David, K., Sommers, V., Walravens, J., Fiers, T., Lapauw, B., Decallonne, B., Claessens, F., Uytfanghe, K. V., et al. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-1237 · Cited by 10
“Apart from the signi fi cant impact of the erroneous sampling interval, there are no full speci fi cations on the “ apparent healthy ” population used, raising questions if health conditionssuchaobesityanddiabeteswereconsideredasthese are known to in fl uence total T [36].”
Self-citationBraga, M. A. P., Rivera, A., Marinheiro, G., Felix, N. S., Carvalho, P. E. P., Gewehr, D. M., Teixeira, L., Clemente, M. R. C., Reis, P. C. A., de Amorim, L. G. C. R., et al. (2025) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-025-00737-w · Cited by 10
Metadata
- Authors
- Wu, F. C. W., Tajar, A., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F., Forti, G., Giwercman, A., Huhtaniemi, I. T., Kula, K., Punab, M., Boonen, S., Vanderschueren, D., & The European Male Aging Study Group
- Affiliations
- Manchester Royal Infirmary (GB)
- University of Manchester (GB)
- Department of ARC Epidemiology Unit (A.T., S.R.P., A.J.S., J.D.F., T.W.O.), The University of Manchester, Manchester M13 9PT, United Kingdom
- Department of Obstetrics, Gynaecology, and Andrology (G.B.), Albert Svent-Gyorgy Medical University, Szeged 6725, Hungary
- Universidade de Santiago de Compostela (ES)
- University of Florence (IT)
- Lund University (SE)
- Imperial College London (GB)
- Medical University of Lodz (PL)
- Tartu University Hospital (EE)
- KU Leuven (BE)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-07-01
- Volume
- 93
- Issue
- 7
- Pages
- 2737-2745
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2155228880
- Semantic Scholar
- 12ac293cf4312c58f80b9c0104201804e7863c96
- Cited by
- 939
- References
- 41
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 48 · 2023: 52 · 2022: 60 · 2021: 55 · 2020: 67 · 2019: 58 · 2018: 56 · 2017: 48 · 2016: 56 · 2015: 58 · 2014: 59 · 2013: 46 · 2012: 48
- FWCI
- 33.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- hypothalamic-pituitary-testicular axis, male aging, testosterone decline, free testosterone, luteinizing hormone, obesity, smoking, comorbidities, sex hormone-binding globulin, testicular function, older men
- MeSH terms
- Adult, Aged, Aging, Alcohol Drinking, Cross-Sectional Studies, Humans, Hypothalamo-Hypophyseal System, Luteinizing Hormone, Male, Middle Aged, Obesity, Risk Factors, Sex Hormone-Binding Globulin, Testis, Testosterone, Comorbidity, Body Mass Index, Waist-Hip Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.